The competition is fierce! Musk once said that "Tirzepatide", which is more effective than semaglutide, will be launched in China. Who will dominate the weight loss drug market in 2025?
① Today, Eli Lilly and Co announced the official launch of tirzepatide in China, covering both type 2 diabetes and weight loss, and it is already available on some online platforms; ② Musk has claimed that tirzepatide is better than semaglutide, while the market is more focused on the pricing of tirzepatide and whether it will be included in medical insurance; ③ The competition in the GLP-1 sector will become even more intense in 2025, with Jiangsu Hengrui Pharmaceuticals, INNOVENT BIO, and Gan & Lee Pharmaceuticals receiving widespread attention.
The rebalancing pace has accelerated! Swiss Re Life invested 29.09 million Hong Kong dollars to increase its shareholding in CHINA LONGYUAN H shares. This year, insurance capital has sparked a new wave of "stake-building."
① This time, Ruizhong Life has increased its stake in CHINA LONGYUAN H shares as part of equity investment management; ② Asset returns are under pressure, and within the year, insurance funds have initiated a new round of "stake acquisition boom"; ③ As of December 25, at least 8 insurance institutions have increased their stakes in 20 listed companies this year.
The countdown for financial companies to exit shareholder equity in financial institutions has begun, as a large number of public offerings, reits, banks, and insurance firms are busy changing shareholders.
① In just over seven months, Cathay Fund completed the change of its third-largest shareholder; ② With the countdown for the clearing ending, financial companies are intensively transferring public offerings, reits, banks, and insurance equity.
China Chengtong accelerates the integration of its papermaking business, Yueyang Forest & Paper plans to "recycle" old assets worth 1.28 billion|Quick announcement
①China Chengtong integrates the papermaking business, mcc meili cloud computing industry investment and yueyang forest & paper are both making moves; ②Yueyang Forest & Paper plans to acquire a pulp company spun off years ago for 1.28 billion in cash / money market; ③The target has had stable profits in the past two years, but Yueyang Forest & Paper's operation continues to be under pressure; ④The target was spun off by Yueyang Forest & Paper in 2015 due to poor performance.
After a public announcement shook the market, shandong chenming paper's AH stock prices both plummeted today, with many banks stating that there is currently no crediting cooperation.
①Affected by related news, shandong chenming paper's AH stocks opened with significant declines today. ②As a star enterprise in shandong, shandong chenming paper once became a key target for banks' public relations and investments. ③Several bank representatives told the China Finance News that there is currently no crediting cooperation with shandong chenming paper. Some banks still have ongoing collaborations, but their exposure is continuously being reduced.
Insurance capital is intensively increasing stakes in dividend stocks! What is the reason?
Currently, there are quite a few shareholders of insurance funds that hold more than 5% of the circulating shares of listed companies. In addition to some being unlocked restricted shares, there have also been many actions of shareholding and new stakes taken, with at least 14 instances of such actions this year.